OPTIMARK

This brand name is authorized in Austria, Brazil, Estonia, Lithuania, South Africa

Active ingredients

The drug OPTIMARK contains one active pharmaceutical ingredient (API):

1 Gadoversetamide UNII RLM74T3Z9D - GADOVERSETAMIDE

Gadoversetamide is a chelate containing gadolinium – which has paramagnetic properties and is responsible for the contrast enhancement effect in MRI – and the ligand versetamide. Gadoversetamide after intravenous administration, equilibrates rapidly within the extracellular fluid/space and is eliminated primarily by glomerular filtration. Read about Gadoversetamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OPTIMARK Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08CA06	Gadoversetamide	V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 524500301157211, 524500302153218, 524500303151219, 524500304156214, 524500305152212, 524500306159210, 524500307155219
Country: EE	Ravimiamet	Identifier(s): 1308046, 1308057, 1308068, 1308079, 1308080, 1308091, 1308103, 1308114, 1308125, 1308147, 1308158, 1308169, 1308170
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1030322, 1030323, 1030324, 1030325, 1030326, 1030327, 1030328, 1030329, 1030330, 1030331, 1030332, 1030333, 1030334, 1030335
Country: ZA	Health Products Regulatory Authority	Identifier(s): 42/28/0102, 42/28/0103, 42/28/0104, 42/28/0105